 | • レポートコード：D0804-14725 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、129ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肛門がんの世界市場を広く調査・分析し、今後の市場展望をまとめております。肛門がんの種類別市場規模（フルオロウラシル、シスプラチン、カルボプラチン、その他）、用途別市場規模（病院、介護センター、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Bayer、Global BioPharma、Spectrum Pharmaceuticals、Atara Biotherapeutics、Hospira、Eli Lilly、Amgen Inc、Advaxis、Cell Medica、Novartis、PDS Biotechnology、Genticel、Ono Pharmaceutical、Millennium Pharmaceuticals、ISA Pharmaceuticals、Sun Pharma、Oryx、Merck＆Co ・地域別グローバル市場分析 2015年-2020年 ・肛門がんの北米市場（アメリカ、カナダ、メキシコ） ・肛門がんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肛門がんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肛門がんの南米市場（ブラジル、アルゼンチン） ・肛門がんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：フルオロウラシル、シスプラチン、カルボプラチン、その他 ・用途別分析：病院、介護センター、薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Anal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anal Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anal Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anal Cancer market has been segmented into:
Fluorouracil
Cisplatin
Carboplatin
Other
By Application, Anal Cancer has been segmented into:
Hospitals
Long-term care centers
Pharmacies
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anal Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Anal Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anal Cancer market.
The report offers in-depth assessment of the growth and other aspects of the Anal Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Anal Cancer Market Share Analysis
Anal Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anal Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anal Cancer sales, revenue and market share for each player covered in this report.
The major players covered in Anal Cancer are:
GlaxoSmithKline
Bayer
Global BioPharma
Spectrum Pharmaceuticals
Atara Biotherapeutics
Hospira
Eli Lilly
Amgen Inc
Advaxis
Cell Medica
Novartis
PDS Biotechnology
Genticel
Ono Pharmaceutical
Millennium Pharmaceuticals
ISA Pharmaceuticals
Sun Pharma
Oryx
Merck＆Co
Table of Contents
1 Anal Cancer Market Overview
1.1 Product Overview and Scope of Anal Cancer
1.2 Classification of Anal Cancer by Type
1.2.1 Global Anal Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anal Cancer Revenue Market Share by Type in 2019
1.2.3 Fluorouracil
1.2.4 Cisplatin
1.2.5 Carboplatin
1.2.6 Other
1.3 Global Anal Cancer Market by Application
1.3.1 Overview: Global Anal Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Long-term care centers
1.3.4 Pharmacies
1.3.5 Other
1.4 Global Anal Cancer Market by Regions
1.4.1 Global Anal Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anal Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anal Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anal Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anal Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anal Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anal Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 Global BioPharma
2.3.1 Global BioPharma Details
2.3.2 Global BioPharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Global BioPharma SWOT Analysis
2.3.4 Global BioPharma Product and Services
2.3.5 Global BioPharma Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 Spectrum Pharmaceuticals
2.4.1 Spectrum Pharmaceuticals Details
2.4.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Spectrum Pharmaceuticals SWOT Analysis
2.4.4 Spectrum Pharmaceuticals Product and Services
2.4.5 Spectrum Pharmaceuticals Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 Atara Biotherapeutics
2.5.1 Atara Biotherapeutics Details
2.5.2 Atara Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Atara Biotherapeutics SWOT Analysis
2.5.4 Atara Biotherapeutics Product and Services
2.5.5 Atara Biotherapeutics Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hospira
2.6.1 Hospira Details
2.6.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hospira SWOT Analysis
2.6.4 Hospira Product and Services
2.6.5 Hospira Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eli Lilly SWOT Analysis
2.7.4 Eli Lilly Product and Services
2.7.5 Eli Lilly Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen Inc
2.8.1 Amgen Inc Details
2.8.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen Inc SWOT Analysis
2.8.4 Amgen Inc Product and Services
2.8.5 Amgen Inc Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.9 Advaxis
2.9.1 Advaxis Details
2.9.2 Advaxis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Advaxis SWOT Analysis
2.9.4 Advaxis Product and Services
2.9.5 Advaxis Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cell Medica
2.10.1 Cell Medica Details
2.10.2 Cell Medica Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cell Medica SWOT Analysis
2.10.4 Cell Medica Product and Services
2.10.5 Cell Medica Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.12 PDS Biotechnology
2.12.1 PDS Biotechnology Details
2.12.2 PDS Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 PDS Biotechnology SWOT Analysis
2.12.4 PDS Biotechnology Product and Services
2.12.5 PDS Biotechnology Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.13 Genticel
2.13.1 Genticel Details
2.13.2 Genticel Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Genticel SWOT Analysis
2.13.4 Genticel Product and Services
2.13.5 Genticel Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.14 Ono Pharmaceutical
2.14.1 Ono Pharmaceutical Details
2.14.2 Ono Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Ono Pharmaceutical SWOT Analysis
2.14.4 Ono Pharmaceutical Product and Services
2.14.5 Ono Pharmaceutical Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.15 Millennium Pharmaceuticals
2.15.1 Millennium Pharmaceuticals Details
2.15.2 Millennium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Millennium Pharmaceuticals SWOT Analysis
2.15.4 Millennium Pharmaceuticals Product and Services
2.15.5 Millennium Pharmaceuticals Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.16 ISA Pharmaceuticals
2.16.1 ISA Pharmaceuticals Details
2.16.2 ISA Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 ISA Pharmaceuticals SWOT Analysis
2.16.4 ISA Pharmaceuticals Product and Services
2.16.5 ISA Pharmaceuticals Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sun Pharma
2.17.1 Sun Pharma Details
2.17.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Sun Pharma SWOT Analysis
2.17.4 Sun Pharma Product and Services
2.17.5 Sun Pharma Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.18 Oryx
2.18.1 Oryx Details
2.18.2 Oryx Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Oryx SWOT Analysis
2.18.4 Oryx Product and Services
2.18.3 Oryx Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.19 Merck＆Co
2.19.1 Merck＆Co Details
2.19.2 Merck＆Co Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Merck＆Co SWOT Analysis
2.19.4 Merck＆Co Product and Services
2.19.5 Merck＆Co Anal Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anal Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anal Cancer Players Market Share
3.2.2 Top 10 Anal Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anal Cancer Revenue and Market Share by Regions
4.2 North America Anal Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Anal Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anal Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Anal Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anal Cancer Revenue and Growth Rate (2015-2020)
5 North America Anal Cancer Revenue by Countries
5.1 North America Anal Cancer Revenue by Countries (2015-2020)
5.2 USA Anal Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Anal Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Anal Cancer Revenue and Growth Rate (2015-2020)
6 Europe Anal Cancer Revenue by Countries
6.1 Europe Anal Cancer Revenue by Countries (2015-2020)
6.2 Germany Anal Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Anal Cancer Revenue and Growth Rate (2015-2020)
6.4 France Anal Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Anal Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Anal Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anal Cancer Revenue by Countries
7.1 Asia-Pacific Anal Cancer Revenue by Countries (2015-2020)
7.2 China Anal Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Anal Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Anal Cancer Revenue and Growth Rate (2015-2020)
7.5 India Anal Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anal Cancer Revenue and Growth Rate (2015-2020)
8 South America Anal Cancer Revenue by Countries
8.1 South America Anal Cancer Revenue by Countries (2015-2020)
8.2 Brazil Anal Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Anal Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anal Cancer by Countries
9.1 Middle East & Africa Anal Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anal Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Anal Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Anal Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Anal Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anal Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Anal Cancer Market Forecast by Type (2019-2024)
10.3 Fluorouracil Revenue Growth Rate (2015-2025)
10.4 Cisplatin Revenue Growth Rate (2015-2025)
10.5 Carboplatin Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Anal Cancer Market Segment by Application
11.1 Global Anal Cancer Revenue Market Share by Application (2015-2020)
11.2 Anal Cancer Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Long-term care centers Revenue Growth (2015-2020)
11.5 Pharmacies Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Anal Cancer Market Size Forecast (2021-2025)
12.1 Global Anal Cancer Market Size Forecast (2021-2025)
12.2 Global Anal Cancer Market Forecast by Regions (2021-2025)
12.3 North America Anal Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Anal Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anal Cancer Revenue Market Forecast (2021-2025)
12.6 South America Anal Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anal Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Anal Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anal Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anal Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anal Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Anal Cancer Major Business
Table 7. GlaxoSmithKline Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Anal Cancer Product and Solutions
Table 10. GlaxoSmithKline Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bayer Corporate Information, Location and Competitors
Table 12. Bayer Anal Cancer Major Business
Table 13. Bayer Anal Cancer Total Revenue (USD Million) (2018-2019)
Table 14. Bayer SWOT Analysis
Table 15. Bayer Anal Cancer Product and Solutions
Table 16. Bayer Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Global BioPharma Corporate Information, Location and Competitors
Table 18. Global BioPharma Anal Cancer Major Business
Table 19. Global BioPharma Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 20. Global BioPharma SWOT Analysis
Table 21. Global BioPharma Anal Cancer Product and Solutions
Table 22. Global BioPharma Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Spectrum Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Spectrum Pharmaceuticals Anal Cancer Major Business
Table 25. Spectrum Pharmaceuticals Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 26. Spectrum Pharmaceuticals SWOT Analysis
Table 27. Spectrum Pharmaceuticals Anal Cancer Product and Solutions
Table 28. Spectrum Pharmaceuticals Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Atara Biotherapeutics Corporate Information, Location and Competitors
Table 30. Atara Biotherapeutics Anal Cancer Major Business
Table 31. Atara Biotherapeutics Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 32. Atara Biotherapeutics SWOT Analysis
Table 33. Atara Biotherapeutics Anal Cancer Product and Solutions
Table 34. Atara Biotherapeutics Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Hospira Corporate Information, Location and Competitors
Table 36. Hospira Anal Cancer Major Business
Table 37. Hospira Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 38. Hospira SWOT Analysis
Table 39. Hospira Anal Cancer Product and Solutions
Table 40. Hospira Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Eli Lilly Corporate Information, Location and Competitors
Table 42. Eli Lilly Anal Cancer Major Business
Table 43. Eli Lilly Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 44. Eli Lilly SWOT Analysis
Table 45. Eli Lilly Anal Cancer Product and Solutions
Table 46. Eli Lilly Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Amgen Inc Corporate Information, Location and Competitors
Table 48. Amgen Inc Anal Cancer Major Business
Table 49. Amgen Inc Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 50. Amgen Inc SWOT Analysis
Table 51. Amgen Inc Anal Cancer Product and Solutions
Table 52. Amgen Inc Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Advaxis Corporate Information, Location and Competitors
Table 54. Advaxis Anal Cancer Major Business
Table 55. Advaxis Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 56. Advaxis SWOT Analysis
Table 57. Advaxis Anal Cancer Product and Solutions
Table 58. Advaxis Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Cell Medica Corporate Information, Location and Competitors
Table 60. Cell Medica Anal Cancer Major Business
Table 61. Cell Medica Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 62. Cell Medica SWOT Analysis
Table 63. Cell Medica Anal Cancer Product and Solutions
Table 64. Cell Medica Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Novartis Corporate Information, Location and Competitors
Table 66. Novartis Anal Cancer Major Business
Table 67. Novartis Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 68. Novartis SWOT Analysis
Table 69. Novartis Anal Cancer Product and Solutions
Table 70. Novartis Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. PDS Biotechnology Corporate Information, Location and Competitors
Table 72. PDS Biotechnology Anal Cancer Major Business
Table 73. PDS Biotechnology Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 74. PDS Biotechnology SWOT Analysis
Table 75. PDS Biotechnology Anal Cancer Product and Solutions
Table 76. PDS Biotechnology Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Genticel Corporate Information, Location and Competitors
Table 78. Genticel Anal Cancer Major Business
Table 79. Genticel Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 80. Genticel SWOT Analysis
Table 81. Genticel Anal Cancer Product and Solutions
Table 82. Genticel Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Ono Pharmaceutical Corporate Information, Location and Competitors
Table 84. Ono Pharmaceutical Anal Cancer Major Business
Table 85. Ono Pharmaceutical Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 86. Ono Pharmaceutical SWOT Analysis
Table 87. Ono Pharmaceutical Anal Cancer Product and Solutions
Table 88. Ono Pharmaceutical Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Millennium Pharmaceuticals Corporate Information, Location and Competitors
Table 90. Millennium Pharmaceuticals Anal Cancer Major Business
Table 91. Millennium Pharmaceuticals Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 92. Millennium Pharmaceuticals SWOT Analysis
Table 93. Millennium Pharmaceuticals Anal Cancer Product and Solutions
Table 94. Millennium Pharmaceuticals Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. ISA Pharmaceuticals Corporate Information, Location and Competitors
Table 96. ISA Pharmaceuticals Anal Cancer Major Business
Table 97. ISA Pharmaceuticals Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 98. ISA Pharmaceuticals SWOT Analysis
Table 99. ISA Pharmaceuticals Anal Cancer Product and Solutions
Table 100. ISA Pharmaceuticals Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Sun Pharma Corporate Information, Location and Competitors
Table 102. Sun Pharma Anal Cancer Major Business
Table 103. Sun Pharma Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 104. Sun Pharma SWOT Analysis
Table 105. Sun Pharma Anal Cancer Product and Solutions
Table 106. Sun Pharma Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Oryx Anal Cancer Type and Application
Table 108. Oryx Anal Cancer Major Business
Table 109. Oryx Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 110. Oryx SWOT Analysis
Table 111. Oryx Anal Cancer Product and Solutions
Table 112. Oryx Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Merck＆Co Corporate Information, Location and Competitors
Table 114. Merck＆Co Anal Cancer Major Business
Table 115. Merck＆Co Anal Cancer Total Revenue (USD Million) (2017-2018)
Table 116. Merck＆Co SWOT Analysis
Table 117. Merck＆Co Anal Cancer Product and Solutions
Table 118. Merck＆Co Anal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Global Anal Cancer Revenue (Million USD) by Players (2015-2020)
Table 120. Global Anal Cancer Revenue Share by Players (2015-2020)
Table 121. Global Anal Cancer Revenue (Million USD) by Regions (2015-2020)
Table 122. Global Anal Cancer Revenue Market Share by Regions (2015-2020)
Table 123. North America Anal Cancer Revenue by Countries (2015-2020)
Table 124. North America Anal Cancer Revenue Market Share by Countries (2015-2020)
Table 125. Europe Anal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 126. Asia-Pacific Anal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 127. South America Anal Cancer Revenue by Countries (2015-2020)
Table 128. South America Anal Cancer Revenue Market Share by Countries (2015-2020)
Table 129. Middle East and Africa Anal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 130. Middle East and Africa Anal Cancer Revenue Market Share by Countries (2015-2020)
Table 131. Global Anal Cancer Revenue (Million USD) by Type (2015-2020)
Table 132. Global Anal Cancer Revenue Share by Type (2015-2020)
Table 133. Global Anal Cancer Revenue Forecast by Type (2021-2025)
Table 134. Global Anal Cancer Revenue by Application (2015-2020)
Table 135. Global Anal Cancer Revenue Share by Application (2015-2020)
Table 136. Global Anal Cancer Revenue Forecast by Application (2021-2025)
Table 137. Global Anal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anal Cancer Picture
Figure 2. Global Anal Cancer Revenue Market Share by Type in 2019
Figure 3. Fluorouracil Picture
Figure 4. Cisplatin Picture
Figure 5. Carboplatin Picture
Figure 6. Other Picture
Figure 7. Anal Cancer Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Long-term care centers Picture
Figure 10. Pharmacies Picture
Figure 11. Other Picture
Figure 12. Global Anal Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Anal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Anal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Anal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Anal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Anal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Anal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Anal Cancer Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Anal Cancer Revenue Market Share in 2019
Figure 21. Global Top 10 Players Anal Cancer Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Anal Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Anal Cancer Revenue Market Share by Regions (2015-2020)
Figure 25. Global Anal Cancer Revenue Market Share by Regions in 2018
Figure 26. North America Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 27. Europe Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 29. South America Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 31. North America Anal Cancer Revenue Market Share by Countries (2015-2020)
Figure 32. North America Anal Cancer Revenue Market Share by Countries in 2019
Figure 33. USA Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 34. Canada Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 36. Europe Anal Cancer Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Anal Cancer Revenue Market Share by Countries in 2019
Figure 38. Germany Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 39. UK Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 40. France Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 41. Russia Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 42. Italy Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Anal Cancer Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Anal Cancer Revenue Market Share by Countries in 2019
Figure 45. China Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 46. Japan Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 47. Korea Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 48. India Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 50. South America Anal Cancer Revenue Market Share by Countries (2015-2020)
Figure 51. South America Anal Cancer Revenue Market Share by Countries in 2019
Figure 52. Brazil Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Anal Cancer Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Anal Cancer Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 57. UAE Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Anal Cancer Revenue and Growth Rate (2015-2020)
Figure 60. Global Anal Cancer Revenue Share by Type (2015-2020)
Figure 61. Global Anal Cancer Revenue Share by Type in 2019
Figure 62. Global Anal Cancer Market Share Forecast by Type (2021-2025)
Figure 63. Global Fluorouracil Revenue Growth Rate (2015-2020)
Figure 64. Global Cisplatin Revenue Growth Rate (2015-2020)
Figure 65. Global Carboplatin Revenue Growth Rate (2015-2020)
Figure 66. Global Other Revenue Growth Rate (2015-2020)
Figure 67. Global Anal Cancer Revenue Share by Application (2015-2020)
Figure 68. Global Anal Cancer Revenue Share by Application in 2019
Figure 69. Global Anal Cancer Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Long-term care centers Revenue Growth Rate (2015-2020)
Figure 72. Global Pharmacies Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Anal Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Anal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Anal Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Anal Cancer Revenue Market Forecast (2021-2025)
Figure 78. Europe Anal Cancer Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Anal Cancer Revenue Market Forecast (2021-2025)
Figure 80. South America Anal Cancer Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Anal Cancer Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
肛門裂傷治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anal Fissure Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.9% in the forecast period of 2020 to 2025 and will expected to reach USD 2032.7 million by 2025, from USD 1616.7 million in 2019. The Anal Fissure …- 胆管がんの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Bile Duct Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 202.1 million by 2025, from USD 156.2 million in 2019. The Bile Duct Cancer mark…
- 大腸がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Colorectal Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 子宮頸癌の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cervical Cancer market report…
- 転移性大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metast…